Skip to contentN
NP Life Sciences Health Industry Group Inc.
N
ACATNP Life Sciences Health Industry Group Inc. Q4 2023 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$10.01K$10.01Kderivedno prior Q4 2022 on file Net Income-$37.68K-$37.68KderivedN/M vs Q4 2022 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NP Life Sciences Health Industry Group Inc. · CIK 1781726 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$35,862N/M Operating Cash Flowderived-$13,937N/M Margins · derivedOperating margin-358.4%
Net margin-376.6%
ended Dec 31, 2023 · filed Apr 16, 2024 · 107 d after period end